| Michael Ross Lewis Jr, MD | |
|
1136 E Grande Blvd, Tyler, TX 75703-3982 | |
| (903) 592-5601 | |
| (903) 595-3304 |
| Full Name | Michael Ross Lewis Jr |
|---|---|
| Gender | Male |
| Speciality | Otolaryngology |
| Experience | 28 Years |
| Location | 1136 E Grande Blvd, Tyler, Texas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1649269119 | NPI | - | NPPES |
| 147525301 | Medicaid | TX |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Y00000X | Otolaryngology | K4733 (Texas) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Christus Mother Frances Hospital | Tyler, TX | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Heaton Ear Nose And Throat Associates Of East Texas P A | 4688774482 | 7 |
News Archive
Conatus Pharmaceuticals Inc. announced today the treatment of the first patient in a multi-center Phase 2b clinical trial evaluating CTS-1027 in combination with Peginterferon Alfa-2a and ribavirin in a treatment experienced, hepatitis C null responder patient population. Safety, tolerability, and antiviral activity of the triple combination will be assessed after up to 48 weeks of therapy.
Patient satisfaction ratings after surgery for spinal degenerative disease—especially in terms of reduced pain and disability—are a good indicator of the procedure's effectiveness, reports a study in the August issue of Neurosurgery, official journal of the Congress of Neurological Surgeons.
"Lab tests have confirmed that a virulent strain of hand, foot and mouth disease known as [enterovirus-71 (EV-71)] is to blame for some of the 59 cases of mysterious illness among children in Cambodia reviewed since April, including 52 deaths, according to a joint statement from the World Health Organization and Cambodian Health Ministry," the Associated Press reports, noting that "the numbers were lowered from the initial report of 62 cases."
The New York Times: "Senate Democrats said on Wednesday that they were not sure exactly what was in a deal that the majority leader said would surmount a disagreement over a proposed government-run health plan. But they voiced guarded optimism that it would ultimately help them pass major health care legislation."
› Verified 1 days ago
| Entity Name | Heaton Ear Nose And Throat Associates Of East Texas P A |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1306988035 PECOS PAC ID: 4688774482 Enrollment ID: O20090120000320 |
News Archive
Conatus Pharmaceuticals Inc. announced today the treatment of the first patient in a multi-center Phase 2b clinical trial evaluating CTS-1027 in combination with Peginterferon Alfa-2a and ribavirin in a treatment experienced, hepatitis C null responder patient population. Safety, tolerability, and antiviral activity of the triple combination will be assessed after up to 48 weeks of therapy.
Patient satisfaction ratings after surgery for spinal degenerative disease—especially in terms of reduced pain and disability—are a good indicator of the procedure's effectiveness, reports a study in the August issue of Neurosurgery, official journal of the Congress of Neurological Surgeons.
"Lab tests have confirmed that a virulent strain of hand, foot and mouth disease known as [enterovirus-71 (EV-71)] is to blame for some of the 59 cases of mysterious illness among children in Cambodia reviewed since April, including 52 deaths, according to a joint statement from the World Health Organization and Cambodian Health Ministry," the Associated Press reports, noting that "the numbers were lowered from the initial report of 62 cases."
The New York Times: "Senate Democrats said on Wednesday that they were not sure exactly what was in a deal that the majority leader said would surmount a disagreement over a proposed government-run health plan. But they voiced guarded optimism that it would ultimately help them pass major health care legislation."
› Verified 1 days ago
| Entity Name | Fyzical Therapy & Balance Center Tyler Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1831695998 PECOS PAC ID: 1254687395 Enrollment ID: O20180703002518 |
News Archive
Conatus Pharmaceuticals Inc. announced today the treatment of the first patient in a multi-center Phase 2b clinical trial evaluating CTS-1027 in combination with Peginterferon Alfa-2a and ribavirin in a treatment experienced, hepatitis C null responder patient population. Safety, tolerability, and antiviral activity of the triple combination will be assessed after up to 48 weeks of therapy.
Patient satisfaction ratings after surgery for spinal degenerative disease—especially in terms of reduced pain and disability—are a good indicator of the procedure's effectiveness, reports a study in the August issue of Neurosurgery, official journal of the Congress of Neurological Surgeons.
"Lab tests have confirmed that a virulent strain of hand, foot and mouth disease known as [enterovirus-71 (EV-71)] is to blame for some of the 59 cases of mysterious illness among children in Cambodia reviewed since April, including 52 deaths, according to a joint statement from the World Health Organization and Cambodian Health Ministry," the Associated Press reports, noting that "the numbers were lowered from the initial report of 62 cases."
The New York Times: "Senate Democrats said on Wednesday that they were not sure exactly what was in a deal that the majority leader said would surmount a disagreement over a proposed government-run health plan. But they voiced guarded optimism that it would ultimately help them pass major health care legislation."
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Michael Ross Lewis Jr, MD 1136 E Grande Blvd, Tyler, TX 75703-3982 Ph: (903) 592-5601 | Michael Ross Lewis Jr, MD 1136 E Grande Blvd, Tyler, TX 75703-3982 Ph: (903) 592-5601 |
News Archive
Conatus Pharmaceuticals Inc. announced today the treatment of the first patient in a multi-center Phase 2b clinical trial evaluating CTS-1027 in combination with Peginterferon Alfa-2a and ribavirin in a treatment experienced, hepatitis C null responder patient population. Safety, tolerability, and antiviral activity of the triple combination will be assessed after up to 48 weeks of therapy.
Patient satisfaction ratings after surgery for spinal degenerative disease—especially in terms of reduced pain and disability—are a good indicator of the procedure's effectiveness, reports a study in the August issue of Neurosurgery, official journal of the Congress of Neurological Surgeons.
"Lab tests have confirmed that a virulent strain of hand, foot and mouth disease known as [enterovirus-71 (EV-71)] is to blame for some of the 59 cases of mysterious illness among children in Cambodia reviewed since April, including 52 deaths, according to a joint statement from the World Health Organization and Cambodian Health Ministry," the Associated Press reports, noting that "the numbers were lowered from the initial report of 62 cases."
The New York Times: "Senate Democrats said on Wednesday that they were not sure exactly what was in a deal that the majority leader said would surmount a disagreement over a proposed government-run health plan. But they voiced guarded optimism that it would ultimately help them pass major health care legislation."
› Verified 1 days ago
Dr. Monica Jane Hardee, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 1136 E Grande Blvd, Tyler, TX 75703 Phone: 903-592-5601 Fax: 903-595-3304 | |
Timothy Dale, Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 1136 E Grande Blvd, Tyler, TX 75703 Phone: 903-592-5601 | |
James Dan Toney, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 630 S Fleishel Ave, Tyler, TX 75701 Phone: 903-533-1491 | |
Christopher A Perro, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 2210 Three Lakes Pkwy Ste 100, Tyler, TX 75703 Phone: 903-747-4050 Fax: 903-747-4075 | |
Scott Fraser Kohlert, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 910 E Houston St Ste 530, Tyler, TX 75702 Phone: 903-606-4300 | |
Howard Scott Garb, MD Otolaryngology Medicare: Medicare Enrolled Practice Location: 1136 E Grande Blvd, Tyler, TX 75703 Phone: 903-592-5601 Fax: 903-595-3304 | |
John Franklin Hudnall, MD Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 3413 Golden Rd, Tyler, TX 75701 Phone: 903-592-5601 Fax: 903-595-3304 |